MAZEE, LLC – Trademark Portfolio

Entity Type: 16

MAZEE, LLC holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 30 (Staple Foods) — 4 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include GLEE and GLEE GUM. The owner is based in NEWARK, NJ.

1 GATEWAY CENTER, SUITE 2600

NEWARK, NJ 07102

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

GLEE
GLEE
Registered 2021
GLEE GUM
GLEE GUM
Registered 2021
GLEE
GLEE
Cancelled 2014
GLEE
GLEE
Registered 2014
GLEE GUM
GLEE GUM
Cancelled 2001

Trademark Classifications

MAZEE, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

30
Staple Foods (4 filings)

Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does MAZEE, LLC have?

MAZEE, LLC has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 cancelled.

What trademark classes does MAZEE, LLC file in?

MAZEE, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 30 (Staple Foods), Class 5 (Pharmaceuticals). Class 30 covers coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations.

What are MAZEE, LLC's most well-known trademarks?

MAZEE, LLC's registered trademark portfolio includes well-known marks such as GLEE and GLEE GUM. These are among 3 currently registered trademarks in the portfolio.

What is MAZEE, LLC's trademark registration success rate?

MAZEE, LLC has a 60% trademark registration rate, with 3 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.